latest tirzepatide news Obesity drug seen as effective for long COVID, gets clinical trial ✨ 𝗠𝗔𝗝𝗢𝗥 𝗨𝗣𝗗𝗔𝗧𝗘: 𝗭𝗘𝗣𝗕𝗢𝗨𝗡𝗗 (𝗧𝗜𝗥𝗭𝗘𝗣𝗔𝗧𝗜𝗗𝗘)

If you want help assessing where your plan stands, book a discovery call.

Touted for its purported ability to influence metabolic pathways related to fat metabolism, this peptide has made ripples in the health and wellness sectors

Doctors and patient advocates say the drugs proved helpful for patients struggling with obesity and can save money in the long run by reducing comorbidities such as heart disease

A randomized controlled trial (RCT) demonstrated that after 6 months of supplementation with 1.2 g/d of EPA + DHA for patients with knee OA, the WOMAC pain score decreased by 23% ( p = 0.02), and the synovial inflammation assessed by MRI was relieved (42)

For Premium Plan members with customised forms, we can add any of these questions and functionality